-
公开(公告)号：US20240189386A1
公开(公告)日：2024-06-13
申请号：US18515425
申请日：2023-11-21
发明人： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
CPC分类号： A61K38/168 , A61K36/82 , A61K38/08 , A61K38/10 , A61P19/00 , A61K2236/19 , A61K2236/333 , A61K2236/39
摘要： The present disclosure relates to a composition for anti-fatigue comprising a green tea peptide composition. Specifically, the green tea peptide composition according to the present disclosure exhibits anti-fatigue efficacy through excellent effects of inhibiting production of fatigue substances within a muscle cell, increasing ATP production within the muscle cell, and promoting fat oxidation within the muscle cell, and can be applied to various health functional food compositions and pharmaceutical compositions.
-
2.发明公开公开(公告)号：US20240226223A1
公开(公告)日：2024-07-11
申请号：US18536404
申请日：2023-12-12
发明人： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
CPC分类号： A61K36/82 , A61K38/168 , A61P21/00 , A61K2236/19 , A61K2236/331 , A61K2236/333
摘要： The present disclosure relates to a composition for preventing, improving, or treating muscle loss comprising a green tea peptide composition. Specifically, the green tea peptide composition according to the present disclosure may exhibit an efficacy in preventing, improving, or treating muscle loss through the excellent effects of increasing protein synthesis in muscle cells and inhibiting protein degradation in the muscle cells, and thus may be applied in various health functional food compositions and pharmaceutical compositions.
-
公开(公告)号：US20230381262A1
公开(公告)日：2023-11-30
申请号：US18325484
申请日：2023-05-30
发明人： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
IPC分类号： A61K36/82 , A61P29/00 , A23L33/105 , A23L2/52 , A23L33/00
CPC分类号： A61K36/82 , A61P29/00 , A23L33/105 , A23L2/52 , A23L33/40
摘要： A method for reducing absorption of a microplastic in a body, including administering a composition including an effective amount of a green tea extract to a subject in need thereof is disclosed in the specification. One aspect of the present disclosure is the composition may be a food composition or a pharmaceutical composition.
-
公开(公告)号：US20210308166A1
公开(公告)日：2021-10-07
申请号：US17266567
申请日：2019-07-02
发明人： Yong Deog HONG , Hyun Woo JEONG
IPC分类号： A61K31/7048 , A61K36/258 , A61K31/7016 , A61K8/9789 , A23L33/105 , A61P39/06 , A61Q19/00
摘要： The present specification relates to a composition comprising (20S,24R)-6-O-β-D-glucopyranosyl(1->2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, and pharmaceutically acceptable salts thereof, a hydrate thereof or a solvate thereof as an active ingredient. The composition exhibits an excellent antioxidant effect.
-
公开(公告)号：US20240181002A1
公开(公告)日：2024-06-06
申请号：US18515599
申请日：2023-11-21
发明人： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
CPC分类号： A61K38/168 , A61P3/04 , A61K2236/19 , A61K2236/333 , A61K2236/37
摘要： The present disclosure relates to a composition for anti-obesity including a green tea peptide composition. Specifically, the green tea peptide composition according to the one aspect of the present disclosure exhibits anti-obesity efficacy through excellent lipid metabolism activation and can be applied to various health functional food compositions and pharmaceutical compositions.
-
公开(公告)号：US20210309693A1
公开(公告)日：2021-10-07
申请号：US17267666
申请日：2019-06-27
发明人： Yong Deog HONG , Hyun Woo JEONG
IPC分类号： C07J17/00 , A61K8/63 , A23L33/105 , A61Q19/00 , A61K9/00
摘要： The present specification relates to (20S,24R)-6-O-β-D-glucopyranosyl(1->2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel ginsenoside exhibits excellent anti-inflammatory effects.
-
公开(公告)号：US20180271830A1
公开(公告)日：2018-09-27
申请号：US15989544
申请日：2018-05-25
发明人： Hyun Jung SHIN , Hyun Woo JEONG , Ji Hae LEE , Dae Jin MIN , Dae Bang SEO , Sang Jun LEE
CPC分类号： A61K31/37 , A23V2002/00 , A61K36/48 , A61K2236/19
摘要： The present invention relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a soybean extract comprising coumestrol as an active ingredient, and more specifically relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a germinated and fermented soybean extract comprising coumestrol as an active ingredient.
-
公开(公告)号：US20160263079A1
公开(公告)日：2016-09-15
申请号：US15160239
申请日：2016-05-20
发明人： Byung Gyu KIM , Hyun Woo JEONG , Su Kyung KIM , Si Young CHO , Chan Woong PARK , Dae Bang SEO , Wan Gi KIM , Sang Jun LEE
IPC分类号： A61K31/34 , A23L2/52 , A61K36/258
CPC分类号： A61K31/34 , A23L2/52 , A23L33/105 , A23L33/11 , A23V2002/00 , A61K36/258
摘要： The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
-
公开(公告)号：US20160263078A1
公开(公告)日：2016-09-15
申请号：US15160218
申请日：2016-05-20
发明人： Byung Gyu KIM , Hyun Woo JEONG , Su Kyung KIM , Si Young CHO , Chan Woong PARK , Dae Bang SEO , Wan Gi KIM , Sang Jun LEE
IPC分类号： A61K31/34 , A61K36/258
CPC分类号： A61K31/34 , A23L2/52 , A23L33/105 , A23L33/11 , A23V2002/00 , A61K36/258
摘要： The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
-
10.发明公开公开(公告)号：US20230372417A1
公开(公告)日：2023-11-23
申请号：US18313465
申请日：2023-05-08
发明人： Hyun Woo JEONG , Donghyun CHO , Wanki KIM , Jong Hwa ROH
IPC分类号： A61K35/747 , A23L33/135 , A61P1/16
CPC分类号： A61K35/747 , A23L33/135 , A61P1/16 , A23Y2220/67
摘要： A method for improving hepatic function, including administering an effective amount of a composition including a green tea-derived Lactiplantibacillus plantarum strain; a culture of the strain; a lysate of the strain; an extract of the strain; an extract of the culture; or an extract of the lysate to a subject in need thereof is disclosed in the specification.
-
-
-
-
-
-
-
-
-
搜索结果
19 条记录 (耗时 0.016 秒)
